Brandon Triplett
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Brandon Triplett as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:13 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07052370 · TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic MalignanciesSt. Jude Children's Research Hospital · recruiting · Hematologic Malignancy · principal investigator
- Ph2NCT03849651 · TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic MalignanciesSt. Jude Children's Research Hospital · active not recruiting · Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) · principal investigator
- Ph2NCT02790515 · Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior TransplantationSt. Jude Children's Research Hospital · active not recruiting · Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma · principal investigator
- Ph2NCT02259348 · Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior TransplantationSt. Jude Children's Research Hospital · terminated · Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma · principal investigator
- Ph2NCT02199041 · Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative RegimenSt. Jude Children's Research Hospital · terminated · Hematological Malignancies · principal investigator
- Ph1NCT00824135 · Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesSt. Jude Children's Research Hospital · completed · Hematologic Malignancies · principal investigator
- N/ANCT00674882 · Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell TransplantSt. Jude Children's Research Hospital · completed · Hematopoietic Stem Cell Transplantation · principal investigator
- Ph2NCT00566696 · Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological MalignanciesSt. Jude Children's Research Hospital · completed · Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML) · principal investigator
- Ph2NCT00145626 · HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic MalignanciesSt. Jude Children's Research Hospital · completed · Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplasia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:13 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- 193 citationsRCR 6.9
- Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.Biol Blood Marrow Transplant · 2013119 citationsRCR 4.2
- Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.Br J Haematol · 2018113 citationsRCR 4.9
- A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia.J Immunother Cancer · 201998 citationsRCR 3.5
- Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.J Clin Oncol · 202294 citationsRCR 6.6
- A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma.Clin Cancer Res · 201975 citationsRCR 2.8
- Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.Blood Adv · 202259 citationsRCR 3.6
- 54 citationsRCR 2.0
- Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.Transpl Infect Dis · 201853 citationsRCR 2.0
- 51 citationsRCR 1.5